Небиволол против неалкогольного стеатогепатита (НАСГ): новая надежда для печени?

Bioorganic Chemistry Volume 163, August 2025, 108755 Targeting fibrosis and steatosis: Nebivolol multi-pathway modulator ameliorates experimental non-alcoholic steatohepatitis in rats through AMPK/mTOR and TGF-β1/α-SMA pathways https://www.sciencedirect.com/science/article/abs/pii/S0045206825006352?via%3Dihub